A carregar...
Survival of patients with KRAS wild-type metastatic colorectal cancer is identical after sequential treatment with cetuximab and bevacizumab regardless of the sequence – A retrospective single-center study
Objective: To investigate the overall survival of patients with KRAS wild-type metastatic colorectal cancer (mCRC) after sequentially receiving both bevacizumab and cetuximab during the course of treatment. Methods: Twenty-six mCRC patients who received both bevacizumab and cetuximab at the Sun Yat-...
Na minha lista:
| Publicado no: | Gastroenterol Rep (Oxf) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4650979/ https://ncbi.nlm.nih.gov/pubmed/26468218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/gov051 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|